- InvestInvestment SuiteExclusiveFeatures
- PlatformProduct SuiteFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketStocksIndicesMutual FundsIPO
- LearnResourceInvesting GuideEvents
- Partner
- Support
Invest
Platform
Research
Market
Learn
Compare Tata India Pharma & Healthcare Fund vs SBI Healthcare Opportunities Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 4.0 | 4.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 2.14 | 1.95 |
NAV | ₹30.80 | ₹426.36 |
Fund Started | 04 Dec 2015 | 04 Jun 1999 |
Fund Size | ₹1213.92 Cr | ₹3459.68 Cr |
Exit Load | Exit load of 0.25% if redeemed within 30 days. | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
4.0
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.14
1.95
NAV
₹30.80
₹426.36
Fund Started
04 Dec 2015
04 Jun 1999
Fund Size
₹1213.92 Cr
₹3459.68 Cr
Exit Load
Exit load of 0.25% if redeemed within 30 days.
Exit load of 0.50% if redeemed within 15 days
Returns
1 Year | 39.38% | 41.33% |
3 Year | 21.53% | 23.49% |
5 Year | 27.37% | 29.35% |
1 Year
39.38%
41.33%
3 Year
21.53%
23.49%
5 Year
27.37%
29.35%
Holding Analysis
Equity | 95.72% | 96.50% |
Cash | 4.28% | 3.50% |
Equity
95.72%
96.50%
Cash
4.28%
3.50%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.80% |
Aurobindo Pharma Ltd. | 7.71% |
Lupin Ltd. | 6.93% |
Cipla Ltd. | 6.19% |
Dr. Reddy's Laboratories Ltd. | 6.09% |
Divi's Laboratories Ltd. | 5.34% |
Fortis Healthcare Ltd. | 4.64% |
Zydus Lifesciences Ltd. | 3.75% |
Alkem Laboratories Ltd. | 3.50% |
Apollo Hospitals Enterprise Ltd. | 3.31% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 12.87% |
Divi's Laboratories Ltd. | 6.42% |
Cipla Ltd. | 5.68% |
Max Healthcare Institute Ltd. | 5.66% |
Lupin Ltd. | 4.74% |
Lonza Group Ag | 4.39% |
Poly Medicure Ltd. | 4.02% |
Krishna Institute of Medical Sciences Ltd | 3.75% |
Jupiter Life Line Hospitals Ltd. | 3.64% |
Aether Industries Ltd. | 3.33% |
Fund Manager
Name | Meeta Shetty | Tanmaya Desai |
Start Date | 09 Nov 2018 | 27 Jun 2011 |
Name
Meeta Shetty
Tanmaya Desai
Start Date
09 Nov 2018
27 Jun 2011
About Fund
Description | The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 04 Dec 2015 | 04 Jun 1999 |
Description
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
04 Dec 2015
04 Jun 1999
